SEC Contract Filing

Filing Date: 2020-02-25

Document Content:
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>a2019exhibit102.htm
<DESCRIPTION>FIRST AMENDMENT TO CREDIT AGREEMENT, DATED AS OF OCTOBER 21, 2019
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
 <!-- Document created using Wdesk 1 -->
 <!-- Copyright 2020 Workiva -->
 <title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sDEE9ECDB5D2699FF11BBD43C31187835"></a></div><div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit 10.2</font></div><div style="line-height:120%;text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">EXECUTION VERSION</font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">FIRST AMENDMENT TO CREDIT AGREEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">THIS FIRST AMENDMENT TO CREDIT AGREEMENT (this &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Amendment</font><font style="font-family:inherit;font-size:10pt;">&#8221;) is entered into as of October 21, 2019 among PERKINELMER, INC., a Massachusetts corporation (the &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Company</font><font style="font-family:inherit;font-size:10pt;">&#8221;), PERKINELMER HEALTH SCIENCES, INC., a Delaware corporation (&#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Health Sciences</font><font style="font-family:inherit;font-size:10pt;">&#8221;), PERKINELMER LIFE SCIENCES INTERNATIONAL HOLDINGS, a company incorporated and registered under the laws of England and Wales with registered number 04418157 (the &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">UK Borrower</font><font style="font-family:inherit;font-size:10pt;">&#8221;), PERKINELMER GLOBAL HOLDINGS S.&#192; R.L., a private limited liability company (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">soci&#233;t&#233; &#224; responsabilit&#233; limit&#233;e</font><font style="font-family:inherit;font-size:10pt;">) incorporated under the laws of Luxembourg, having its registered office at 9, all&#233;e Scheffer, L-2520 Luxembourg-city, Luxembourg, registered with the Luxembourg Trade and Companies Register (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">registre de commerce et des soci&#233;t&#233;s, Luxembourg</font><font style="font-family:inherit;font-size:10pt;">) under number B217121 (the &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Luxembourg Borrower</font><font style="font-family:inherit;font-size:10pt;">&#8221;), PERKINELMER HEALTH SCIENCES B.V., a private company with limited liability incorporated under the laws of the Netherlands (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">besloten vennootschap met beperkte aansprakelijkheid</font><font style="font-family:inherit;font-size:10pt;">) having its official seat (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">statutaire zetel</font><font style="font-family:inherit;font-size:10pt;">) in Groningen, and its office at Groningen, Rigaweg 22 (9723TH), registered with the Dutch Trade Register of the Chamber of Commerce under number 02027119 (the &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Dutch Borrower</font><font style="font-family:inherit;font-size:10pt;">&#8221;; the Dutch Borrower, together with the Company, Health Sciences, the UK Borrower, and the Luxembourg Borrower, each a &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Borrower</font><font style="font-family:inherit;font-size:10pt;">&#8221; and collectively, the &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Borrowers</font><font style="font-family:inherit;font-size:10pt;">&#8221;), the Lenders party hereto, and BANK OF AMERICA, N.A., as the Administrative Agent. All capitalized terms used herein and not otherwise defined herein shall have the meanings given to such terms in the Credit Agreement (as defined below).</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">RECITALS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WHEREAS, the Borrowers, the Designated Borrowers from time to time party thereto, the Lenders from time to time party thereto, Bank of America, N.A., as the Administrative Agent, the Swing Line Lender and an L/C Issuer, and the other L/C Issuers party hereto, entered into that certain Credit Agreement, dated as of September 17, 2019 (as amended, restated, amended and restated, supplemented, extended, replaced or otherwise modified from time to time, the &#8220;</font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Credit Agreement</font><font style="font-family:inherit;font-size:10pt;">&#8221;);</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">WHEREAS, the Borrowers have requested that the Credit Agreement be amended as set forth below, subject to the terms and conditions specified in this Amendment; and</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;text-indent:48px;font-siz